EDGC Diagnomics Logo

The Eone-Diagnomics Genome Center (EDGC) is a newly established biotech-healthcare company in Songdo Inchon, Korea. The company focuses on innovative products and service development for personalized medicine based on Next Generation Sequencing (NGS) technology and cutting edge genomics analysis.

Our goal is to provide high quality healthcare products and services to guide personalized medicine based on an individuals' genetic information. Eone-Diagnomics provides various personal genome sequencing and bioinformatics solutions to biomedical researchers, physicians and individuals seeking to understand the genetic influence of personal health and disease. Led by internationally recognized scientists, physicians and engineers, our team successfully sequenced and analyzed many normal and diseased human genomes including individuals with various cancers and rare genetic diseases.

Our vision is to develop cutting-edge diagnostic tools and a complete solution for personal genome sequencing and analysis, which will enable interpretation of individual genomes to be part of routine medical care. We are thriving to provide individualized strategies for diagnosing, treating and preventing disease based on information obtained from personal genomes.

Diagnomics E1 Genome Center (EDGC)

EDGC is an international joint venture (JV) established in 2013 between the Eone Life Science Institute in Korea and Diagnomics, Inc. in California, USA. The new combined entity's unique strength is derived from merging two distinct expertises and experiences to synergize for new technology development for the creation of a new type of healthcare.

EONE Laboratories slide show (pdf)

EONE-Diagnomics Genome Center (EDGC) brochure (pdf)

Diagnomics e1 Genome Center Composite

Eone Life Science provides 30 years of know-how and experience in clinical diagnostics and reference lab expertise in Korea, and Diagnomics contributes cutting edge genomics and next generation sequencing expertise from the USA to revolutionize next generation healthcare from personalized medicine. The company is located in the international business district in Songdo Inchon Korea, and near the Inchon international Airport - the main hub for air transportation in East Asia.

The prime location for international business together with expertise from two excellent partners (INTEL and Illumina) provides an unprecedented opportunity for developing and commercializing new technology and creating new kinds of business.

Diagnomics e1 Genome Center Composite Diagnomics e1 Genome Center Composite Diagnomics e1 Genome Center Composite Diagnomics e1 Genome Center Composite Diagnomics e1 Genome Center Composite Diagnomics e1 Genome Center Composite Diagnomics e1 Genome Center Composite Diagnomics e1 Genome Center Composite Diagnomics e1 Genome Center Composite Diagnomics e1 Genome Center Composite Diagnomics e1 Genome Center Joint Venture